Vulnerability in Baxter Prismaflex
CVE-2020-12036
Baxter PrismaFlex all versions, PrisMax all versions prior to 3.x, The affected devices do not implement data-in-transit encryption (e.g., TLS/SSL) when configured to send treatment data to a PDMS (Patient Data Management System) or an EMR (Electronic Medical Record) system. An attacker could observe sensitive data sent from the device.
EPSS: 0.005 (39.7th percentile) — read the EPSS interpretation.
CVSS v3 metric
CVSS v3 base score 7.5 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N.
Affected products
- Baxter Prismaflex
- Baxter Prismaflex_firmware
- Baxter Prismax
- Baxter Prismax_firmware
- N/a Baxter Prismaflex And Prismax — versions PrismaFlex all versions, PrisMax all versions prior to 3.x
Weakness classification (CWE)
References
- ics-cert@hq.dhs.gov (x_refsource_MISC, Not Applicable)
Frequently asked questions
- What is CVE-2020-12036?
- CVE-2020-12036 is a high-severity vulnerability in Baxter Prismaflex, classified under Cleartext Transmission of Sensitive Information. CVSS score: 7.5/10. Published 2020-06-29.
- How severe is CVE-2020-12036?
- High severity. CVSS v3 base score is 7.5 out of 10.